A recent report utilised a mutant EGFR (deletion 19)-expressing NSCLC cell line HCC827, which is highly sensitive to gefitinib, an in vitro gefitinib-resistance long-term inhibition culture system to select for gefitinib-resistant cell subclones (Engelman et al, 2007). This evidence concerns the gene EGFR and non-small cell lung carcinoma.